Maryam Asgari, MD

Professor, Dermatology


FacultyPhoto
Medical School
  • MD, Yale University School of Medicine (1997)
Graduate School
  • MPH, University of Washington (2003)
Undergraduate School
  • BS, Stanford University (CA) (1992)
  • AB, Stanford University (CA) (1992)
Internship
  • Beth Israel Deaconess Medical Center Program (1998)
Residency
  • University of Washington Program, Dermatology (2002)
Fellowships
  • University of Texas Southwestern Medical School Program, Procedural Dermatology (2005)
Department
Dermatology

Professional Titles

  • Professor and Chair of Dermatology

Recognitions

  • Excellence in Innovation, Massachusetts General Hospital - Harvard Medical School (2017)
    Awarded for innovative in skin cancer detection.
  • Founder's Award, Dermatoepidemiology Network (2024)
    Awarded for lifetime achievement in the field of dermatoepidemiology.

Research Interests

I am a physician-scientist trained in Mohs micrographic surgery who specializes in skin cancer management. I dedicate my time to clinical research focused on skin cancer risk and outcomes.

Publications

  • Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 Jan 5;7(1):33. PubMed PMID: 38182794
  • George CD, Lee T, Hollestein L, Asgari MM, Nijsten T. The Global Epidemiology of Actinic Keratosis in the General Population: A Systematic Review and Meta-Analysis. Br J Dermatol. 2023 Oct 27. [Epub ahead of print] PubMed PMID: 37890083
  • Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 Feb;90(2):288-298. PubMed PMID: 37797836
  • Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 Jul;112(1):E27-E29. PubMed PMID: 37611292
  • Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 Jul 1;159(7):788-790. PubMed PMID: 37256610
  • Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 Apr 18;329(15):1259-1260. PubMed PMID: 37071108
  • Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 Apr;143(4):664-667. PubMed PMID: 36343677
  • Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug;315(6):1583-1592. PubMed PMID: 36749390
  • Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 Mar 10;13(3):e071172. PubMed PMID: 36898743
  • Tan AJ, Archila M, Barbieri JS, Mostaghimi A, Scherer AM, Perez-Chada LM, Asgari MM, Gelfand JM, Noe MH. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study. Arch Dermatol Res. 2024 Apr 18;316(5):125. PubMed PMID: 38637431
  • Safaei Jazi S, Faniayeu I, Cichelero R, Tzarouchis DC, Asgari MM, Dmitriev A, Fan S, Asadchy V. Optical Tellegen metamaterial with spontaneous magnetization. Nat Commun. 2024 Feb 12;15(1):1293. PubMed PMID: 38346950
  • Lee T, George CD, Jiang C, Asgari MM, Nijsten T, Pardo LM, Choquet H. Association between lifetime smoking and cutaneous squamous cell carcinoma: A 2-sample Mendelian randomization study. JAAD Int. 2024 Mar;14:69-76. PubMed PMID: 38274396
  • Choquet H, Jiang C, Yin J, Kim Y, Hoffmann TJ, Jorgenson E, Asgari MM. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma. Commun Biol. 2024 Jan 5;7(1):33. PubMed PMID: 38182794
  • George CD, Lee T, Hollestein LM, Asgari MM, Nijsten T. Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis. Br J Dermatol. 2024 Mar 15;190(4):465-476. PubMed PMID: 37890083
  • Wan G, Leung BW, DeSimone MS, Nguyen N, Rajeh A, Collier MR, Rashdan H, Roster K, Zhou X, Moseley CB, Nirmal AJ, Pelletier RJ, Maliga Z, Marko-Varga G, Németh IB, Tsao H, Asgari MM, Gusev A, Stagner AM, Lian CG, Hurlbert MS, Liu F, Yu KH, Sorger PK, Semenov YR. Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma. J Am Acad Dermatol. 2024 Feb;90(2):288-298. PubMed PMID: 37797836
  • Kim Y, Yin J, Le Breton S, Jorgenson E, Huang H, Choquet H, Asgari MM. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2023 Apr;143(4):664-667. PubMed PMID: 36343677
  • Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug;315(6):1583-1592. PubMed PMID: 36749390
  • Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 Mar 10;13(3):e071172. PubMed PMID: 36898743
  • Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 Jul;112(1):E27-E29. PubMed PMID: 37611292
  • Ashrafzadeh S, Foreman RK, Kalra S, Mandinova A, Asgari MM. Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize. JAMA Dermatol. 2023 Jul 1;159(7):788-790. PubMed PMID: 37256610
  • Asgari MM, Crane LA. Skin Cancer Screening: The Importance of Identifying High-risk Subgroups and the Need for US-Based Population Research. JAMA. 2023 Apr 18;329(15):1259-1260. PubMed PMID: 37071108

Practice Locations

UCHealth Dermatology Clinic - Anschutz Medical Campus
1665 Aurora Ct
3rd Floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-0500

CU Medicine Dermatology – Montview Blvd (CU Medicine Building)
13199 E Montview Blvd Ste 300
Aurora, CO 80045
(303) 315-5085

Specialty Information

Specialties
  • Dermatology, Board Certification (2002, 2022)
  • Mohs Surgery, Board Certification (2024)
  • Procedural Dermatology (Mohs), Specialized Training (2004)
Conditions & Treatments
  • Cancers - Skin Cancer
  • Cancers
Clinical Interests
Squamous cell carcinoma, basal cell carcinoma, Merkel cell carcinoma, melanoma.

Care Philosophy
I have a holistic view of patient care delivery which involves attention and care to the whole individual, not just their skin cancer. I strive to make my patients feel welcome, relaxed and professionally cared for during their time with me.